Alerion Partners

About The Fund

Alerion Partners, also known as BioGenerator Ventures, is an investment fund that focuses on creating, building, and investing in companies addressing significant problems in human health and agriculture. With over $39 million invested into startups and an impressive leverage of over 60 times of invested capital, BioGenerator Ventures has facilitated a significant amount of capital raised by its companies, totaling more than $2.6 billion. The fund runs a portfolio of over 50 active investments in sectors ranging from therapeutics and diagnostics to medical devices, research tools, agriculture, and healthcare. Supporting startups across various stages, BioGenerator Ventures specializes in providing seed and startup capital and is characterized as a Startup Studio. Their expertise spans both equity and debt financing. A unique feature of the fund is the BioGenerator Labs, which offer a suite of tools designed to accelerate new ventures. These tools include technology, proof of concept grants, coaching, grant training, and innovative laboratory space. The labs have played a pivotal role in sprouting successful companies in a short time frame. BioGenerator Ventures' investment is often followed by value-adding contributions such as providing access to BioGenerator Labs and connecting portfolio companies with follow-on funds and other capital attraction services. The fund also plays a critical role in company formation and strategy, offering mentorship, capital, and critical infrastructure support to its ventures. Moreover, the success of BioGenerator Ventures is also reflected in the successful exits of portfolio companies, such as acquisitions by large industry players and public offerings. Based in St. Louis, Missouri, their model and investment strategy showcase a commitment to fostering innovation and growth within the life sciences and agtech sectors, contributing to a thriving startup ecosystem in the region.